Staphylococcal pyrogenic exotoxin (PE) types A and B were tested for their role in production of a scarlatiniform rash. The PEs elicited minimal skin reactions after intracutaneous injection into animals not presensitized to the toxins. In contrast, erythematous and edematous rashes were produced after administration of either PE to animals presensitized to homologous toxin. After 3 to 4 days, the erythematous areas showed membranous desquamation. Staphylococcal PEs also enhanced delayed and Arthus hypersensitivity skin reactions developed against unrelated proteins; the reactions subsequently desquamated. In addition, animals previously sensitized to either staphylococcal PE type developed scarlatiniform rashes after challenge with heterologous staphylococcal or any group A streptococcal PE. The data suggest that staphylococcal PEs produce scarlet fever-like rashes comparable to group A streptococcal PEs and that all PE types contain a common core moiety against which delayed hypersensitivity may be developed.
Staphylococcal pyrogenic exotoxin (PE) types A and B were tested for their role in production of a scarlatiniform rash. The PEs elicited minimal skin reactions after intracutaneous injection into animals not presensitized to the toxins. In contrast, erythematous and edematous rashes were produced after administration of either PE to animals presensitized to homologous toxin. After 3 to 4 days, the erythematous areas showed membranous desquamation. Staphylococcal PEs also enhanced delayed and Arthus hypersensitivity skin reactions developed against unrelated proteins; the reactions subsequently desquamated. In addition, animals previously sensitized to either staphylococcal PE type developed scarlatiniform rashes after challenge with heterologous staphylococcal or any group A streptococcal PE. The data suggest that staphylococcal PEs produce scarlet fever-like rashes comparable to group A streptococcal PEs and that all PE types contain a common core moiety against which delayed hypersensitivity may be developed.
Syndromes closely related to classical group A streptococcal scarlet fever have resulted from infection with Staphylococcus aureus. Stevens describes three individuals with staphylococcal scarlet fever, none of whom had a streptococcal infection (20) . Other investigators described scarlet fever in patients with staphylococcal osteomyelitis (1) , wrist infection (6), or leg abscess (10) . In two instances, injection of culture supernatant fluids of the corresponding S. aureus strain into Dick-positive persons resulted in scarlatiniform rashes (1, 10) .
Previously, it was suggested that group A streptococcal pyrogenic exotoxins (PEs) produce the classical scarlet fever rash by enhancing acquired skin reactivity to streptococcal antigens (15) . This included enhancement of hypersensitivity skin reactions developed against the "common core" moiety shared by all three streptococcal PE types (3, 8, 9, 15) . Based on these data, it was concluded that erythrogenic toxin represents the enhancement of hypersensitivity reactions by PEs (15) .
Recently, two serologically distinct staphylococcal PEs were purified and characterized biochemically and biologically (17; P. M. Schlievert, Biochemistry, in press). These toxins share many important properties with the group A streptococcal PEs (2, 3, 5, 12, 13, (17) (18) (19) and may therefore contribute to the development of staphylococcal scarlet fever. In addition, it was proposed that the staphylococcal toxins may contribute to the development of two severe scarlet fever-like syndromes, Kawasaki disease (17; Schlievert, in press ). The purpose of this investigation was to assess the role of staphylococcal PEs in production of the scarlatiniform rash. In addition, PEs from both S. aureus and group A streptococci were tested for the presence of the shared common core moiety.
MATERIALS AND METHODS
All reagents and glassware used for preparation of PEs and biological assays were maintained pyrogen free.
Bacteria. Staphylococcal PEs were obtained from the Hanisburg strain of S. aureus (17) . Group A streptococcal PEs were prepared after culture of strains 594, T18P, and T19P (16) . Microorganisms were maintained in the lyophilized state in the presence of whole defibrinated fresh rabbit blood.
Toxin preparation. PEs were prepared after culture of the organisms in a dialyzable beef heart medium (22) . PEs were purified by differential precipitation with ethanol and resolubilization in either acetate-buffere saline (8) or distilled water (17), followed by preparative thin-layer isoelectric focusing (14). Toxin concentrations were measured by the microbiuret protein assay (23) .
Animals. Darkly pigmented rabbits weighed 2.0 to 2.5 kg.
Assay for pyrogenicity. Assays for the capacity of PEs to produce fever were performed by the 4-h method of Kim and Watson (8, 22 thematous and edematous skin reactions after intracutaneous challenge with homologous toxin (Table 1) . The reaction diameters obtained in these animals were different from those obtained in nonsensitized animals at the P < 0.001 level of significance. The skin reactions in the sensitized animals were comparable in appearance to the enhanced reactivity obtained in a previous study in which group A streptococcal PEs were used as sensitizing and challenge toxins (15) . At 3 to 4 days after challenge with the staphylococcal toxins, membranous desquamation around the challenge sites was observed. When the rabbits were resensitized with staphylococcal PEs and then challenged again with homologous toxin, the average skin reaction of some of the animals was diminished ( Table  2 ). This reduction in skin reactivity in these rabbits corresponded to the development of immunity to the pyrogenicity of the PEs (Fig. 1) . The remaining animals again showed significant skin reactivity (Table 2 ) and also were not immune to the pyrogenicity of the challenge PE (Fig. 1 ).
Staphylococcal PEs were tested for capacity to enhance hypersensitivity skin reactions developed against unrelated proteins in rabbits. Animals presensitized to PPD showed significant enhanced skin reactivity on one flank when challenged with PPD plus PE (Table 3) , compared to the other flank which received PPD alone. Exotoxin alone given to rabbits presensitized to PPD elicited skin reactions comparable to those shown in Table 1 ministered to rabbits immunized against BSA produced minimal skin reactions, and again the values were subtracted from those obtained after challenge with BSA plus PE.
Previously, group A streptococcal PEs were shown to contain a common core moiety which was shared between toxin types (3, 8, 9, 15) . Delayed hypersensitivity that was developed against the common core of one PE type conferred delayed hypersensitivity on the other PE types, and enhancement of skin reactivity to the common core resulted in the typical scarlatiniform rash (15) . Staphylococcal PEs were tested for the presence of the common core related to that of the group A streptococcal PEs ( shown to contain a shared common core moiety, against which delayed hypersensitivity can be developed, as well as serologically specific primary toxic components, which are responsible for enhancing skin reactivity (8, 9, 15) . Therefore, once delayed hypersensitivity was developed against one PE type, the scarlet fever rash could be produced by any streptococcal PE type without further sensitization. In this study, data were presented which indicate that staphylococcal PEs also produce erythematous and edematous rashes by the enhancement of acquired hypersensitivity. This property is consistent with the PEs' being responsible for the clinical signs of staphylococcal scarlet fever and supports a recent proposal that the staphylococcal PEs may contribute to the development of Kawasaki disease and toxic shock syndrome (Schlievert et al., submitted for publication), both of which must be distinguished from classical streptococcal scarlet fever (4, 7, 11, 21) . Also, data were presented which demonstrated that all PEs, whether streptococcal or staphylococcal, shared the common core component of the toxins. This observation is significant since it suggests that scarlet fever or related diseases may be produced up to five times, twice by S. aureus and three times by group A streptococci, and that prior sensitization with one PE type is sufficient for development of the scarlatiniform rash after the host encounters either the homologous or any heterologous PE. The shared common core of all PE types also is consistent with reports that Dick-positive individuals show positive skin reactions when challenged with staphylococcal filtrates (1, 10 
